Skip to content

Author

Hengzhi Li

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Anti-breast cancer effects of the Xingxiao Pill are associated with inhibition of the ErbB3/PI3K/AKT/mTOR pathway, modulation of amino acid metabolism, and promotion of apoptosis.

ETHNOPHARMACOLOGICAL RELEVANCE The Xingxiao Pill (XXP), a representative traditional Chinese medicine (TCM) formula used to promote blood circulation and remove blood stasis in tumor therapy, has shown promising clinical potential. According to the book Famous Traditional Chinese Medicine Formulas and Case Studies for...

Jingyue Zhang, Jian-Bang Cheng, Feng-Chuan Cao et al. · 0 citations
Open access Aug 2026

2'-O-Galloylhyperin attenuates osteoclastogenesis and estrogen-deficiency osteoporosis by targeting MLK3-mediated NF-κB signaling.

Estrogen deficiency-induced osteoporosis is largely driven by excessive osteoclast formation and bone resorption, but the direct pharmacological targets of flavonoid derivatives in osteoclast differentiation remain unclear. Here, we investigated the anti-osteoclastogenic activity and molecular mechanism of 2'-O-Galloyl...

Gaolu He, Ruihan Chen, Zhiyu Fang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.